The stock market is always full of surprises, with some companies experiencing significant gains while others face losses. In this article, we will take a closer look at some of the top gainers and losers in the stock market during Friday’s after-market session.
Gainers:
1. Salarius Pharmaceuticals (SLRX): Shares of Salarius Pharmaceuticals rose by an impressive 33.9% to $0.83, with a market value of $3.2 million.
2. Masimo (MASI): Masimo saw a 12.48% increase in its shares, reaching $151.77, with a market cap of $8.0 billion.
3. Vicarious Surgical (RBOT): Vicarious Surgical’s shares moved up by 11.17% to $0.38, with a market value of $66.7 million.
4. Universe Pharmaceuticals (UPC): Universe Pharmaceuticals’ stock rose by 11.11% to $2.2, with a market cap of $8.0 million.
5. Psyence Biomedical (PBM): Psyence Biomedical’s stock increased by 9.09% to $1.2, with a market cap of $16.0 million.
6. Bright Green (BGXX): Bright Green saw a rise of 8.02% in its shares, reaching $0.29, with a market cap of $53.2 million.
Losers:
1. NextCure (NXTC): NextCure experienced a decline of 9.5% in its shares, reaching $1.72, with a market value of $47.9 million following the release of its Q4 earnings report.
2. Rockwell Medical (RMTI): Rockwell Medical’s shares declined by 7.02% to $1.59, with a market value of $46.3 million after its Q4 earnings report.
3. Mesoblast (MESO): Mesoblast saw a 6.49% decrease in its shares, reaching $2.02, with a market cap of $204.9 million.
4. Trevena (TRVN): Trevena’s stock declined by 6.36% to $0.43, with a market value of $7.8 million.
5. Shuttle Pharmaceuticals (SHPH): Shuttle Pharmaceuticals’ shares decreased by 6.03% to $0.42, with a market cap of $6.7 million after the release of its Q4 earnings report.
6. Nutriband (NTRB): Nutriband’s stock fell by 5.93% to $2.54, with a market value of $21.4 million.
It is essential for investors to stay informed about the latest market trends and company performances to make informed decisions. This article was generated by Benzinga’s automated content engine and reviewed by an editor, providing readers with valuable insights into the stock market movements.
